Tumor-Infiltrating Myeloid Cells Confer De Novo Resistance to PD-L1 Blockade through EMT-Stromal and Tgfβ-Dependent Mechanisms.

Overview of attention for article published in Molecular Cancer Therapeutics, September 2022

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (78th percentile)
High Attention Score compared to outputs of the same age and source (86th percentile)

So far, Altmetric has seen 14 X posts from 11 X users, with an upper bound of 11,569 followers.

Tumor-Infiltrating Myeloid Cells Confer De Novo Resistance to PD-L1 Blockade through EMT–Stromal and Tgfβ-Dependent Mechanisms. https://t.co/dWbpXsCRHm https://t.co/OiDwc9tqsa

RT @TischCancer: Tumor-Infiltrating Myeloid Cells Confer De Novo Resistance to PD-L1 Blockade through EMT–Stromal and Tgfβ-Dependent Mechan…

RT @TischCancer: Tumor-Infiltrating Myeloid Cells Confer De Novo Resistance to PD-L1 Blockade through EMT–Stromal and Tgfβ-Dependent Mechan…

Tumor-Infiltrating Myeloid Cells Confer De Novo Resistance to PD-L1 Blockade through EMT–Stromal and Tgfβ-Dependent Mechanisms https://t.co/mSrwaNJHxc @DrJohnSfakianos @MattGalsky @BhardwajLab @IcahnMountSinai #bladdercancer

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 10 additional X posts.